![Kirsten Flowers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kirsten Flowers
Director/Board Member at
PMV PHARMACEUTICALS, INC.
Net worth: - $ as of 29/06/2026
Profile
Kirsten Flowers is currently an Independent Director at PMV Pharmaceuticals, Inc. since 2022 and a Director at Comera Life Sciences, Inc. Former roles include Independent Director at Comera Life Sciences Holdings, Inc., Senior Vice President-Commercial Operations at Array BioPharma, Inc. from 2017 to 2019, and Chief Commercial & Strategy Officer at Kura Oncology, Inc. from 2020 to 2023.
Education includes an undergraduate degree from the University of Arizona and an MBA from Harvard Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 03/06/2026 | 0 ( -.--% ) | - $ | 29/06/2026 |
Kirsten Flowers active positions
| Companies | Position | Start |
|---|---|---|
| PMV PHARMACEUTICALS, INC. | Director/Board Member | 04/01/2022 |
Comera Life Sciences, Inc.
 Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic medicines | Director/Board Member | - |
Former positions of Kirsten Flowers
| Companies | Position | End |
|---|---|---|
| KURA ONCOLOGY, INC. | Corporate Officer/Principal | 26/01/2023 |
| ARRAY TECHNOLOGIES, INC. | Corporate Officer/Principal | 31/12/2018 |
| COMERA LIFE SCIENCES HOLDINGS, INC. | Director/Board Member | - |
Training of Kirsten Flowers
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
49
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Kura Oncology, Inc.
 Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PMV Pharmaceuticals, Inc.
 PMV Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in discovery and development of small molecule, tumor-agnostic therapies targeting p53 | Health Technology |
Comera Life Sciences, Inc.
Comera Life Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic medicines | Health Technology |
Comera Life Sciences Holdings, Inc.
 Comera Life Sciences Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines | Health Technology |
- Stock Market
- Insiders
- Kirsten Flowers
